British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-alpha; treatments

Rheumatology

Volumn 44, Issue 10, 2005, Pages 1205-1206

  Ledingham, Jo M ^b   Wilkinson, C ^a   Deighton, C ^a  

^a DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACCURACY; ALGORITHM; DRUG CONTRAINDICATION; EDITORIAL; ETHNOLOGY; HUMAN; MEDICAL EDUCATION; MEDICAL SOCIETY; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELIABILITY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCREENING TEST; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; UNITED KINGDOM;

ANTIRHEUMATIC AGENTS; GREAT BRITAIN; HUMANS; OPPORTUNISTIC INFECTIONS; PRACTICE GUIDELINES; RISK ASSESSMENT; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27144544479     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei103     Document Type: Editorial

References (8)

1. Keane J. TNF-blocking agents and tuberculosis: New drugs illuminate an old topic. Rheumatology 2005;44:714-20.
2. Fischkoff S. Preliminary analysis of phase i and ii safety data from the adalimumab (D2E7) clinical trials program. Proceedings of Advances in Targeted Therapies Meeting, April 27-May 2001.
3. Mohan AK, Cote TR, Block JA, Manadan AM, Siegel JN, Braun MM. Tuberculosis following the use of etanercept, a tumour necrosis factor inhibitor. Clin Infect Dis 2004;39:295-9.
4. Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004;50:372-9.
5. Ormerod LP, Milburn HJ, Gillespie S, Ledingham J, Rampton D. BTS recommendations for assessing risk, and for managing M tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 2005;60:800-5.
6. Joint Committee on Vaccination and Immunisation. Tuberculin testing. In: Vaccination and immunisation, Chapter 32. London: HMSO, 1996.
7. National Institute for Clinical Excellence. Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. Health Technology Guidance No. 36. London: National Institute for Clinical Excellence, 2002.
8. Wilkinson CE, Deighton C. Do the proposed recommendations for assessing tuberculosis risk in patients due to start anti-TNF therapy alter resource use? Rheumatology 2005;44(Suppl. 1):i67-8.